SCHEMBL7455159

SCHEMBL7455159

Cc1cccc(-c2c(C)[c]ccc2C)c1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 3/20 0.41
HEXA P06865 1/20 0.40
HEXB P07686 1/20 0.40
ACHE P22303 1/20 0.39
ALDH1A1 P00352 2/20 0.38
MEN1 O00255 1/20 0.38
KMT2A Q03164 1/20 0.38
CNR1 P21554 2/20 0.37
CNR2 P34972 2/20 0.37
L3MBTL1 Q9Y468 1/20 0.37
NPC1 O15118 2/20 0.36
HPGD P15428 2/20 0.36
SMN1; SMN2 Q16637 2/20 0.36
TSHR P16473 1/20 0.36
TP53 P04637 1/20 0.36
POLB P06746 1/20 0.36
HSD17B10 Q99714 1/20 0.36
NOTUM Q6P988 1/20 0.36
IDO1 P14902 1/20 0.35
METAP2 P50579 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2525468 0.82 ALDH1A1 (0.33) HEXAHEXBACHEALDH1A1CNR2
SCHEMBL4284518 0.82 HSD17B1 (0.46) ACHE
SCHEMBL439377 0.80 BRD4 (0.37) RAB9AACHEALDH1A1KMT2ANPC1
SCHEMBL16344216 0.80 RAB9A (0.37) RAB9AHEXAHEXBACHEALDH1A1
SCHEMBL31236143 0.78 ACHE (0.52) RAB9AHEXAHEXBACHEALDH1A1
SCHEMBL17180554 0.77 TAAR1 (0.38) RAB9AALDH1A1KMT2ANPC1SMN1; SMN2
SCHEMBL3992773 0.76 ACHE (0.35) HEXAHEXBACHEALDH1A1MEN1
SCHEMBL8589881 0.74 MAPT (0.39) RAB9AACHEALDH1A1MEN1KMT2A
SCHEMBL10987049 0.72 RAPGEF4 (0.31) ALDH1A1
SCHEMBL6168418 0.72 ALDH1A1 (0.39) RAB9AALDH1A1MEN1KMT2AHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1261611-A2 INHIBITORS OF HEPATITIS C VIRUS NS3 PROTEASE Bristol-Myers Squibb Pharma Company (US) 2002-12-04 EP disclosed
WO-2001064678-A2 INHIBITORS OF HEPATITIS C VIRUS NS3 PROTEASE BRISTOL-MYERS SQUIBB PHARMA COMPANY (US) 2001-09-07 WO disclosed
EP-0830392-A1 SUPPORTED CATALYST COMPOSITION FOR POLYMERIZATION OF OLEFINS W.R. Grace & Co.-Conn. (US) 1998-03-25 EP disclosed
EP-0830385-A1 HALOGENATED SUPPORTS AND SUPPORTED ACTIVATORS W.R. Grace & Co.-Conn. (US) 1998-03-25 EP disclosed
WO-1996040804-A1 SUPPORTED CATALYST COMPOSITION FOR POLYMERIZATION OF OLEFINS W.R. GRACE & CO.-CONN. (US) 1996-12-19 WO disclosed